Press Release

Sickle Cell Disease Treatment Market – Detailed Analysis of Current Industry Figures with Forecasts Growth By 2026

Increasing impetus to research on gene therapy to treat sickle cell disease is a key factor contributing to the Global Sickle Cell Disease Treatment Market Size, says Fortune Business Insights in a report, titled “Sickle Cell Disease Treatment Market Size, Share and Global Trend by Treatment (Blood Transfusions, Medications, Bone Marrow Transplant, Others) and Geography Forecast till 2026.” The rising prevalence of sickle disease around the world is driving the global sickle cell disease treatment market.

Request a Sample Copy of the Global Sickle Cell Disease Treatment Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sickle-cell-disease-treatment-market-101009

Approval of Vexelotor by FDA Will Accelerate Growth

Global Blood Therapeutics (GBT), launched Voxelotor after receiving the Breakthrough Therapy Designation (BTD) from the FDA. Voxelotor, (previously called GBT440), will be used for the treatment of sickle cell disease (SCD). The launch of the new drug is predicted to boost the global sickle cell disease treatment revenue owing to the FDA’s decision to grant Voxelotor the first Breakthrough Therapy designation for the treatment of sickle. Furthermore, FDA approval for the treatment of severe complications associated with sickle cell disease is also expected to aid growth of the global sickle cell disease treatment market. For instance, Emmaus Medical, Inc., Endari received FDA approval for treatment of severe complications associated with sickle cell disease in adult and pediatric (above 5 years) patients. Endari is the second drug to be approved by the FDA.

Key players leading the global surgical robots market include

  • Emmaus Medical Inc.,
  • bluebird bio Inc.,
  • Imara Inc.,
  • Modus Therapeutics,
  • Global Blood Therapeutics Inc.,
  • Vertex Pharmaceuticals Incorporated,

Segmentation

By Treatment

  • Blood Transfusions
  • Medications
  • Bone Marrow Transplant
  • Others

By Geography

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

More Trending Topics From Fortune Business Insights:

Multiple Myeloma Market Share

Multiple Myeloma Market size

Multiple Myeloma Market Share

Multiple Myeloma Market size

Opioid Use Disorder (OUD) Market Share

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close